A critical advance in cancer study is emerging with the use of mini-antibodies to restore mutated p53. This crucial cancer inhibitor protein is frequently inactivated in various forms of tumors, resulting uncontrolled https://atozbookmarkc.com/story22161681/nanobodies-revive-p53-a-promising-pathway-for-cancer-management